200 likes | 918 Views
Clinical Issues in the Management of Non Communicable Diseases. Dr Gyaneshwar Rao Colonial War Memorial Hospital Suva. Presentation Outline. NCD Conditions Fiji Step Survey 2002 Diabetes and Related Issues Fiji Dialysis Centre Hypertension Coronary Angiographic Services.
E N D
Clinical Issues in the Management of Non Communicable Diseases Dr Gyaneshwar Rao Colonial War Memorial Hospital Suva
Presentation Outline • NCD Conditions • Fiji Step Survey 2002 • Diabetes and Related Issues • Fiji Dialysis Centre • Hypertension • Coronary Angiographic Services
Non Communicable Diseases • Diabetes • Hypertension • Ischaemic Heart Disease • Stroke • Rheumatic Heart Disease • Cancers
Disease Trends in the Pacific I N C I D E N C E Communicable diseases Non-communicable diseases Ancient Past 1700s Present
Fiji Step Survey 2002 Diabetes - 16% • Hypertension - 19 • Weight : Obese - 18 Overweight - 28 • Hyperlipidaemia F/M 38/49
Fiji NCD Steps Survey 2002 • Sample Population • 6,783 participants • M 53%; F 47% • 15 – 64 years Percentage
Screening for Type 2 Diabetes • Preclinical phase : 10 – 12 yrs • Tight Control : Micro/Macrovascular • Screening (FBS) : Symtomatic : Asymptomatic • Pre diabetics - studies, long term
Effectiveness of Early Detection and Treatment of Type 2 Diabetes • Diabetes – no trial done • Hypertension - reduces CVD by 50% • Lipid Control • Aspirin – reduces CAD • Other lifestyle factors
Microvascular - Eye - renal - neuropathy Macrovascular - coronary, PVD - cerebrovascular - renovascular Assessing Diabetic Complications
Self Monitoring of blood glucose in type 2 Diabetes • Established practice • Benefit - on insulin - oral drugs • Systemic reviews & Clinical Trials HbA1c - 0.25%, 0.39% DiGEM trial – 0.17%
Early Insulin Therapy • Microvascular • Macrovascular • Beta cell function
Diabetes and Macrovascular Disease • DCCT (Diabetes Control Complication Trial) • UKPDS ( United Kingdom Prospective Diabetic Study)- 25% reduction in microvascular • ACCORD ( The Action to Control Cardiovascular Risk in Diabetic Study Group) • ADVANCE ( The Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified ReleaseControlled Evaluation)
Diabetic Nephropathy • Early Detection • Protein restriction • ACE Inhibitors • Hyperglycaemia • Hypertension • Hyperlipidaemia • Other vascular risk factors
Mild Hypertension • Cut off level • Period of observation • Indications - diabetics - chronic kidney disease - target organ damage - multiple risk factors - vascular disease • Choice of drugs
Difficult Hypertension • Compliance • Diet • Secondary cause • Diuretic
Angiogram – SPH CABG Angiogram Suite Coronary Artery Disease
Thank You Health is Wealth